Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Earnings Yield Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings yield ratio
Latest
-12.21%
↑ 78% above average
Average (8y)
-56.14%
Historical baseline
Range
High:-0.43%
Low:-280.95%
CAGR
+40.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -12.21% | +95.7% |
| 2023 | -280.95% | -96.2% |
| 2022 | -143.22% | -159.3% |
| 2021 | -55.24% | -1245.2% |
| 2020 | -4.11% | +26.7% |
| 2019 | -5.60% | -106.5% |
| 2018 | -2.71% | -535.7% |
| 2017 | -0.43% | +47.6% |
| 2016 | -0.81% | - |